Cargando…
Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome
The objective of this study is to assess tumour response to neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer using magnetic resonance (MR) to monitor tumour volume and changes in molecular profile and to compare the survival to that of a control group. Eligibility included S...
Autores principales: | deSouza, N M, Soutter, W P, Rustin, G, Mahon, M M, Jones, B, Dina, R, McIndoe, G A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409522/ https://www.ncbi.nlm.nih.gov/pubmed/15162152 http://dx.doi.org/10.1038/sj.bjc.6601870 |
Ejemplares similares
-
Clinicopathological risk factors for recurrence after neoadjuvant chemotherapy and radical hysterectomy in cervical cancer
por: Wang, Huali, et al.
Publicado: (2013) -
Perioperative Complications and Safety Evaluation of Robot-Assisted Radical Hysterectomy of Cervical Cancer After Neoadjuvant Chemotherapy
por: Chang, Wei-Fu, et al.
Publicado: (2020) -
Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for Cervical Cancer Patients Effectively Improves Immune Function
por: Liu, Mo, et al.
Publicado: (2022) -
The Outcome of Locally Advanced Cervical Cancer in Patients Treated with Neoadjuvant Chemotherapy Followed by Radical Hysterectomy and Primary Surgery
por: Mousavi, Azamsadat, et al.
Publicado: (2021) -
Retracted: Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for Cervical Cancer Patients Effectively Improves Immune Function
por: Markers, Disease
Publicado: (2023)